Literature DB >> 6587008

Low platelet monoamine oxidase activity in headache: no correlation with phenolsulphotransferase, succinate dehydrogenase, platelet preparation method or smoking.

J Littlewood, V Glover, M Sandler, R Peatfield, R Petty, F Clifford Rose.   

Abstract

Platelet monoamine oxidase activity in male migrainous and cluster headache patients was significantly lower than in male controls, confirming our previous study. The activity range showed a normal distribution and low mean values could not be attributed to a subgroup with particularly low activity. When Corash 's platelet preparation method was used, with its high platelet yield, specific enzyme activities of a similar order were obtained. Thus, the low values encountered were not due to abnormal recovery within the platelet population. Two other enzyme activities, phenolsulphotransferase M and succinate dehydrogenase, were also measured in the same platelet samples. Although low succinate dehydrogenase activity was identified in the headache groups, it appeared to represent a separate phenomenon and there was no significant correlation between activity of either enzyme and that of monoamine oxidase. This shows that the low activity of platelet monoamine oxidase in headache is not related to a generalised platelet enzyme deficit. It was also shown that the low monoamine oxidase activity in the headache patients could not be attributed to smoking.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6587008      PMCID: PMC1027773          DOI: 10.1136/jnnp.47.4.338

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  Platelet dysfunction in migraine: effect of self-medication with aspirin.

Authors:  S V Deshmukh; J S Meyer; R J Mouche
Journal:  Thromb Haemost       Date:  1976-11-30       Impact factor: 5.249

2.  Low platelet monoamine oxidase activity in cigarette smokers.

Authors:  L Oreland; C J Fowler; D Schalling
Journal:  Life Sci       Date:  1981-12-14       Impact factor: 5.037

3.  Platelet heterogeneity: relevance to the use of platelets to study psychiatric disorders.

Authors:  L Corash
Journal:  Schizophr Bull       Date:  1980       Impact factor: 9.306

4.  Platelet monoamine oxidase activity and headache.

Authors:  V Glover; R Peatfield; R Zammit-Pace; J Littlewood; M Gawel; F C Rose; M Sandler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-09       Impact factor: 10.154

5.  The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity.

Authors:  M S Buchsbaum; R D Coursey; D L Murphy
Journal:  Science       Date:  1976-10-15       Impact factor: 47.728

6.  Migraine: a platelet disorder.

Authors:  E Hanington; R J Jones; J A Amess; B Wachowicz
Journal:  Lancet       Date:  1981-10-03       Impact factor: 79.321

7.  Platelet monoamine oxidase: specific activity and turnover number in headache.

Authors:  K M Summers; G K Brown; I W Craig; J Littlewood; R Peatfield; V Glover; F C Rose; M Sandler
Journal:  Clin Chim Acta       Date:  1982-05-20       Impact factor: 3.786

8.  Platelet MAO activity and personality characteristics. A study in schizophrenic patients and normal individuals.

Authors:  W F Gattaz; H Beckmann
Journal:  Acta Psychiatr Scand       Date:  1981-05       Impact factor: 6.392

9.  2-year follow-up of subjects and their families defined as at risk for psychopathology on the basis of platelet MAO activities. 2-year follow-up of low platelet MAO.

Authors:  R D Coursey; M S Buchsbaum; D L Murphy
Journal:  Neuropsychobiology       Date:  1982       Impact factor: 2.328

10.  Platelet aggregability in migraine.

Authors:  J R Couch; R S Hassanein
Journal:  Neurology       Date:  1977-09       Impact factor: 9.910

View more
  5 in total

Review 1.  A possible role for mitochondrial dysfunction in migraine.

Authors:  S Stuart; L R Griffiths
Journal:  Mol Genet Genomics       Date:  2012-10-07       Impact factor: 3.291

2.  Prevalence and risk of migraine headaches in adult fragile X premutation carriers.

Authors:  J Au; R S Akins; L Berkowitz-Sutherland; H-T Tang; Y Chen; A Boyd; F Tassone; D V Nguyen; R Hagerman
Journal:  Clin Genet       Date:  2013-02-21       Impact factor: 4.438

3.  Studies on the pathophysiology and genetic basis of migraine.

Authors:  Claudia F Gasparini; Heidi G Sutherland; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2013-08       Impact factor: 2.236

Review 4.  Mitochondrial Impairment: A Common Motif in Neuropsychiatric Presentation? The Link to the Tryptophan-Kynurenine Metabolic System.

Authors:  Masaru Tanaka; Ágnes Szabó; Eleonóra Spekker; Helga Polyák; Fanni Tóth; László Vécsei
Journal:  Cells       Date:  2022-08-21       Impact factor: 7.666

Review 5.  The metabolic face of migraine - from pathophysiology to treatment.

Authors:  Elena C Gross; Marco Lisicki; Dirk Fischer; Peter S Sándor; Jean Schoenen
Journal:  Nat Rev Neurol       Date:  2019-10-04       Impact factor: 42.937

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.